Legal & General Group PLC Exelixis, Inc. Transaction History

Legal & General Group PLC

$440 Billion
Q2 2024

A detailed history of Legal & General Group PLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 621,249 shares of EXEL stock, worth $16.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

621,249

Previous 675,052 7.97%

Holding current value

$16.1 Million

Previous $16 Million 12.85%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$20.34 - $23.73 $1.09 Million - $1.28 Million	-53,803 Reduced 7.97%	621,249 $14 Million
Q1 2024 May 14, 2024	SELL	$20.17 - $23.93 $1.13 Million - $1.34 Million	-55,815 Reduced 7.64%	675,052 $16 Million
Q4 2023 Feb 15, 2024	SELL	$19.25 - $24.13 $378,166 - $474,033	-19,645 Reduced 2.62%	730,867 $17.5 Million
Q3 2023 Nov 14, 2023	SELL	$19.04 - $22.74 $499,228 - $596,242	-26,220 Reduced 3.38%	750,512 $16.4 Million
Q2 2023 Aug 14, 2023	SELL	$18.17 - $20.48 $575,643 - $648,826	-31,681 Reduced 3.92%	776,732 $14.8 Million
Q1 2023 May 15, 2023	BUY	$16.3 - $19.41 $431,526 - $513,860	26,474 Added 3.39%	808,413 $15.7 Million
Q4 2022 Feb 14, 2023	BUY	$14.96 - $17.39 $161,762 - $188,038	10,813 Added 1.4%	781,939 $12.5 Million
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $46,491 - $66,030	2,965 Added 0.39%	771,126 $12.1 Million
Q2 2022 Aug 22, 2022	BUY	$17.44 - $23.16 $1.06 Million - $1.41 Million	60,994 Added 8.63%	768,161 $16 Million
Q1 2022 May 16, 2022	BUY	$17.03 - $22.67 $178,883 - $238,125	10,504 Added 1.51%	707,167 $16 Million
Q4 2021 Feb 14, 2022	SELL	$15.84 - $21.88 $208,200 - $287,590	-13,144 Reduced 1.85%	696,663 $12.7 Million
Q3 2021 Nov 15, 2021	BUY	$16.3 - $21.14 $861,846 - $1.12 Million	52,874 Added 8.05%	709,807 $15 Million
Q2 2021 Aug 12, 2021	SELL	$17.95 - $25.56 $1.09 Million - $1.55 Million	-60,745 Reduced 8.46%	656,933 $12 Million
Q1 2021 May 17, 2021	BUY	$20.53 - $25.22 $260,443 - $319,940	12,686 Added 1.8%	717,678 $16.2 Million
Q4 2020 Feb 12, 2021	SELL	$18.39 - $24.8 $370,613 - $499,794	-20,153 Reduced 2.78%	704,992 $14.1 Million
Q3 2020 Nov 13, 2020	BUY	$20.67 - $26.94 $359,244 - $468,217	17,380 Added 2.46%	725,145 $17.7 Million
Q2 2020 Aug 14, 2020	BUY	$16.46 - $27.42 $4.39 Million - $7.31 Million	266,516 Added 60.4%	707,765 $16.8 Million
Q1 2020 May 14, 2020	BUY	$14.46 - $21.8 $39,779 - $59,971	2,751 Added 0.63%	441,249 $7.6 Million
Q4 2019 Feb 13, 2020	BUY	$15.15 - $18.89 $590,592 - $736,388	38,983 Added 9.76%	438,498 $7.73 Million
Q3 2019 Nov 13, 2019	BUY	$17.68 - $22.65 $560,933 - $718,616	31,727 Added 8.63%	399,515 $7.07 Million
Q2 2019 Aug 14, 2019	BUY	$18.93 - $24.75 $352,760 - $461,216	18,635 Added 5.34%	367,788 $7.86 Million
Q1 2019 May 15, 2019	BUY	$19.6 - $24.76 $77,870 - $98,371	3,973 Added 1.15%	349,153 $8.31 Million
Q4 2018 Feb 15, 2019	BUY	$13.65 - $21.8 $253,439 - $404,760	18,567 Added 5.68%	345,180 $6.79 Million
Q3 2018 Nov 20, 2018	BUY	$15.87 - $22.4 $268,488 - $378,963	16,918 Added 5.46%	326,613 $5.79 Million
Q2 2018 Aug 10, 2018	BUY	$18.56 - $22.45 $2.82 Million - $3.41 Million	151,752 Added 96.08%	309,695 $6.67 Million
Q1 2018 May 17, 2018	BUY	$22.15 - $31.89 $50,502 - $72,709	2,280 Added 1.46%	157,943 $3.5 Million
Q4 2017 Feb 13, 2018	BUY	$24.23 - $30.93 $3.77 Million - $4.81 Million	155,663	155,663 $4.73 Million

Others Institutions Holding EXEL

# of Institutions

460

Shares Held

240M

Call Options Held

2.04M

Put Options Held

1.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $8.35B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Exelixis, Inc. Transaction History